🇺🇸 FDA

Company profile · Sponsor

Sunshine

Sunshine Biopharma

SBFM · NYSE biotech FORT LAUDERDALE, FL, USA
Pipeline
24
Drugs
12
Patents
8

Quick answer

Sunshine (SBFM) is a biotech company. headquartered in FORT LAUDERDALE, FL, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 12 drugs, and 8 patents to this profile..

Company facts

Ticker SBFM
Exchange NYSE
Company type biotech
Headquarters FORT LAUDERDALE, FL, USA
SEC CIK 0001402328

Pipeline (24)

Search pipeline →

  1. 1% Clascoterone Cream

    Sunshine

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  2. 5% minoxidil foam

    Sunshine

    Androgenetic Alopecia

    phase 3 small molecule active

    1 trial

  3. 601 1.25mg

    Sunshine

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

  4. 608

    Sunshine

    Axial Spondyloarthritis, Non-Radiographic

    phase 3 small molecule active

    1 trial

  5. 608 Q2W

    Sunshine

    Plaque Psoriasis Patients

    phase 3 small molecule active

    1 trial

  6. 608 Q2W

    Sunshine

    Psoriasis

    phase 3 small molecule completed

    1 trial

  7. 608 dose

    Sunshine

    Ankylosing Spondylitis

    phase 3 small molecule active

    1 trial

  8. 610

    Sunshine

    Asthma

    phase 3 small molecule active

    2 trials

  9. 611

    Sunshine

    Pulmonary Disease, Chronic Obstructive (COPD)

    phase 3 small molecule active

    1 trial

  10. 611

    Sunshine

    Sinusitis

    phase 3 small molecule active

    2 trials

  11. 611

    Sunshine

    Dermatitis, Atopic

    phase 3 small molecule active

    3 trials

  12. Clascoterone

    Sunshine

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  13. Clifutinib

    Sunshine

    Leukemia, Acute Myeloid (AML)

    phase 3 small molecule active

    1 trial

  14. EPREX®

    Sunshine

    Renal Anemia

    phase 3 small molecule completed

    1 trial

  15. Etanercept

    Sunshine

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  16. HEC585

    Sunshine

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 3 small molecule active

    1 trial

  17. HEC74647PA+HEC110114

    Sunshine

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  18. Human Erythropoiesis Injection (CHO cell)

    Sunshine

    Kidney Failure, Chronic

    phase 3 small molecule active

    1 trial

  19. Insulin Degludec and Insulin Aspart

    Sunshine

    Diabetes

    phase 3 small molecule completed

    1 trial

  20. Lerotinib

    Sunshine

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  21. Mitizodone Phosphate tablets

    Sunshine

    Depressive Disorder, Major

    phase 3 small molecule active

    1 trial

  22. Nalfurafine Hydrochloride

    Sunshine

    Uremic Pruritus

    phase 3 small molecule active

    1 trial

  23. Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg

    Sunshine

    Acute Gout

    phase 3 small molecule active

    2 trials

  24. SOF

    Sunshine

    Chronic HCV Infection

    phase 3 small molecule completed

    2 trials

Drugs (12)

Search drugs →

  1. apixaban

    APIXABAN ACCORD

    FILM COATED approved

    B01AF02

  2. brivaracetam

    BRIVIACT (IN ITALY: NUBRIVEO)

    ORAL approved

    N03AX23

  3. clarithromycin

    CLARITHROMYCIN

    ORAL approved

  4. duloxetine hydrochloride

    DULOXETINE HYDROCHLORIDE

    ORAL approved

  5. febuxostat

    ADENURIC

    ORAL approved

    M04AA03

  6. insulin glargine-aldy

    LANGLARA

    SUBCUTANEOUS approved

  7. linagliptin

    JENTADUETO

    ORAL approved

    A10BD11

  8. metoprolol succinate

    METOPROLOL SUCCINATE

    ORAL approved

  9. mirabegron

    BETMIGA

    ORAL approved

    G04BD12

  10. moxifloxacin hydrochloride

    MOXIFLOXACIN HYDROCHLORIDE

    OPHTHALMIC approved

  11. rivaroxaban

    RIVAROXABAN ACCORD

    ORAL approved

    B01AF01

  12. technetium tc-99m bicisate kit

    NEUROLITE

    INJECTION approved

Patents (8)

Search patents →

  1. US 12428432

    Thienopyrimidine derivatives having stereo configurations and use thereof in medicine

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12428389

    Diarylamide compound and application thereof

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12384853

    Anti-HER2/PD1 bispecific antibody

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12324812

    Glucopyranosyl derivatives and their uses

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12319748

    Antibody binding to human HER2 and preparation method and use thereof

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12312348

    RET inhibitors, pharmaceutical compositions and uses thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12269886

    Tetravalent bispecific antibody against PD-1 and PD-L1

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12258317

    Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Sunshine?

Sunshine (SBFM) is a biotech company. headquartered in FORT LAUDERDALE, FL, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 12 drugs, and 8 patents to this profile..

What pipeline programs does Sunshine sponsor?

We track 24 ClinicalTrials.gov-linked programs for Sunshine, including 1% Clascoterone Cream and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sunshine company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.